Volume 5 Issue 1
Jun.  2021
Turn off MathJax
Article Contents
Article Navigation >  Blood&Genomics  > 2021  >  5(1): 68-72
Siegfried Janz. Impact of the sympathetic nervous system on multiple myeloma[J]. Blood&Genomics, 2021, 5(1): 68-72. doi: 10.46701/BG.2021012021107
Citation: Siegfried Janz. Impact of the sympathetic nervous system on multiple myeloma[J]. Blood&Genomics, 2021, 5(1): 68-72. doi: 10.46701/BG.2021012021107
shu

Impact of the sympathetic nervous system on multiple myeloma

doi: 10.46701/BG.2021012021107

  • Division of Hematology and Oncology Medical College of Wisconsin, Milwaukee 53226, WI, USA

More Information
  • Corresponding author: *Corresponding to: Siegfried Janz, Tel: +1-414- 955-5784, E-mail: sjanz@mcw.edu
  • Received Date: 2021-03-14
  • Accepted Date: 2021-05-18
  • Rev Recd Date: 2021-04-20
  • Publish Date: 2021-06-01
    Abstract
    • FullText(HTML)
  • loading
    • References(8)
  • [1]
    Cheng Y, Sun FM, D'Souza A, et al. Autonomic nervous system control of multiple myeloma[J]. Blood Rev, 2021, 46: 100741. doi: 10.1016/j.blre.2020.100741
    [2]
    Hwa YL, Shi Q, Kumar SK, et al. Beta-blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation[J]. Am J Hematol, 2017, 92(1): 50−55. doi: 10.1002/ajh.24582
    [3]
    Knight JM, Kerswill SA, Hari P, et al. Repurposing existing medications as cancer therapy: design and feasibility of a randomized pilot investigating propranolol administration in patients receiving hematopoietic cell transplantation[J]. BMC Cancer, 2018, 18(1): 593. doi: 10.1186/s12885-018-4509-0
    [4]
    Knight JM, Rizzo JD, Hari P, et al. Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial[J]. Blood Adv, 2020, 4(3): 467−476. doi: 10.1182/bloodadvances.2019000765
    [5]
    Azoulay D, Giryes S, Nasser R, et al. Prediction of chemotherapy-induced peripheral neuropathy in patients with lymphoma and myeloma: the roles of brain-derived neurotropic factor protein levels and a gene polymorphism[J]. J Clin Neurol, 2019, 15(4): 511−516. doi: 10.3988/jcn.2019.15.4.511
    [6]
    Shastri A, Budhathoki A, Barta SK, et al. Stimulation of adrenergic activity by desipramine enhances hematopoietic stem and progenitor cell mobilization along with G-CSF in multiple myeloma: a pilot study[J]. Am J Hematol, 2017, 92(10): 1047−1051. doi: 10.1002/ajh.24843
    [7]
    Lamkin DM, Sloan EK, Patel AJ, et al. Chronic stress enhances progression of acute lymphoblastic leukemia via β-adrenergic signaling[J]. Brain, Behav, Immun, 2012, 26(4): 635−641. doi: 10.1016/j.bbi.2012.01.013
    [8]
    Arranz L, Sánchez-Aguilera A, Martín-Pérez D, et al. Neuropathy of haematopoietic stem cell niche is essential for myeloproliferative neoplasms[J]. Nature, 2014, 512(7512): 78−81. doi: 10.1038/nature13383
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (23) PDF downloads(0) Cited by()
    Proportional views
    Related

    Copyright © Blood and Genomics苏公网安备 32028102000501号苏ICP备14047883号-3

    Address：Rooms 1318-19, Hollywood Plaza, 610 Nathan Road, Mongkok, Kowloon, HongKong

    E-mail：editorial_office@apjbg.com

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return